Azar Baradaran
1, Saeed Mardani
2, Mohammad-Reza Tamadon
3, Heshmatollah Shahbazian
4, Seyed Seifollah Beladi Mousavi
4*1 Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.
2 Department of Nephrology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
3 Department of Nephrology, Semnan University of Medical Sciences, Semnan, Iran.
4 Chronic Renal Failure Research Center, Ahvaz Junishapur University of Medical Sciences, Ahvaz, Iran.
Implication for health policy/practice/research/medical education
Recent clinical and preclinical investigations have detected glucose and lipid-lowering effects of sevelamer, which imply the role of this drug in the treatment of type II diabetic patients.
Please cite this paper as: Baradaran A, Mardani S, Tamadon MR, Shahbazian H, Beladi Mousavi SS. Sevelamer, a phosphate-binding resin with beneficial effect in diabetic kidney disease; a modern paradigm shift. J Parathyr Dis 2014; 2(2): 61-62.